These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 4803477)

  • 21. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs.
    Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorimetric determination of methyl parathion and oxygen analog.
    Nanda Kumar NV; Ramasundari M
    J Assoc Off Anal Chem; 1980 May; 63(3):536-8. PubMed ID: 7430041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations.
    Sogorb MA; García-Argüelles S; Carrera V; Vilanova E
    Chem Res Toxicol; 2008 Aug; 21(8):1524-9. PubMed ID: 18597495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase polymorphism in northwestern Indians.
    Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acid nonspecific esterase activity in human lymphocytes (author's transl)].
    Liao YT
    Zhonghua Nei Ke Za Zhi; 1981 Jun; 20(6):352-4. PubMed ID: 7318591
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydrolysis of O,O-dimethyl-2,2-dichlorovinyl phosphate (DDVP) by esterases in parasitic helminths, and in vertebrate plasma and erythrocytes.
    Reiner E; Simeon V; Skrinjarić-Spoljar M
    Comp Biochem Physiol C Comp Pharmacol; 1980; 66(2):149-52. PubMed ID: 6107198
    [No Abstract]   [Full Text] [Related]  

  • 30. Polymorphism of plasma esterases in flounder and plaice.
    de Ligny W
    Genet Res; 1968 Apr; 11(2):179-82. PubMed ID: 5647629
    [No Abstract]   [Full Text] [Related]  

  • 31. Inactivity of enkephaline on human serum esterase.
    Gero A
    Life Sci; 1976 Aug; 19(4):479-81. PubMed ID: 957883
    [No Abstract]   [Full Text] [Related]  

  • 32. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
    Eckerson HW; Romson J; Wyte C; La Du BN
    Am J Hum Genet; 1983 Mar; 35(2):214-27. PubMed ID: 6301268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current problems on the structure and classification of mammalian liver carboxylesterases (EC 3.1.1.1).
    Junge W; Krisch K
    Mol Cell Biochem; 1973 May; 1(1):41-52. PubMed ID: 4610350
    [No Abstract]   [Full Text] [Related]  

  • 34. [On kinetics of the paraoxon hydrolysing enzyme in human serum (EC 3.1.1.2) (author's transl)].
    Flügel M; Geldmacher-von Mallinckrodt M
    Klin Wochenschr; 1978 Sep; 56(18):911-6. PubMed ID: 713421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Letter: Comments in response to genetically determined polymorphism of human serum paraxonase (EC 3.1.1.2) (author's transl)].
    Geldmacher Mallinckrodt ; Lindorf HH; Petenyi M; Flügel M; Fischer T; Hiller T
    Humangenetik; 1973 Sep; 19(3):353-6. PubMed ID: 4763943
    [No Abstract]   [Full Text] [Related]  

  • 37. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
    Deakin S; Leviev I; Brulhart-Meynet MC; James RW
    Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the specifity of human serum paraoxonase (author's transl)].
    Geldmacher-von Mallinckrodt M; Pétényi M; Flügel M; Burgis H; Dietzel B; Metzner H; Nirschl H; Renner O
    Hoppe Seylers Z Physiol Chem; 1973 Mar; 354(3):337-40. PubMed ID: 4803477
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.